Dear colleague, 

Once again, we wish you an excellent 2024!

For Cerba, 2023 was a dynamic year full of challenges:

Medical innovation at the service of your patients

In 2023, an ever-expanding range of tests to support you in your day-to-day work and open up new diagnostic and management perspectives for your patients.
 

 Medical Genetics

Optical mapping, a new-generation post-natal cytogenetic diagnostic test

+ More than 150 gene panels in our catalogue
14 medical specialities

Development of custom panels

HLA typing by NGS

 Infectiology

Arbovirosis triplex PCR

  Onco-haematology

Multiple myeloma NGS panel (175 genes)

   Neurology

Dosage of 2nd generation anti-depressants

    Endocrinology

Endocrine disruptors: phthalates and bisphenols panels

   Oncology

HRD by Shallow Whole Genome Sequencing (sWGS)

Cholangiocarcinoma panel

Pancreas panel (BRCA1, BRCA2 and KRAS)

Large Oncosomatic Panel (634 genes) (Clinical trials)

The Cerba International Customer Service Team
intgb@lab-cerba.com